Legacy App users can now access the Health Portal – just reset your password using email as username.

Research Report: World’s Largest Survey of Men on Steroids – What We Learned

Research Report: World’s Largest Survey of Men on Steroids – What We Learned

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:00
The segment introduces a large survey of men using anabolic-androgenic steroids worldwide. It explains that limited physician education motivated building a harm-reduction evidence base.
02:28
Study design details include eligibility within five years of steroid use and adult age requirements. It outlines outcomes like starting age, dosing habits, motivation patterns, and healthcare interactions.
03:33
Motivations are reviewed, with appearance and strength cited alongside self-esteem driven use. Body image distress is discussed as a pathway toward risky steroid decisions for some respondents.
04:31
Disclosure patterns show that fewer than half told their physician about steroid use. Among those who disclosed, many reported judgment that discouraged future medical openness.
06:00
A perception ranking compares coaches, online sources, and physicians for steroid knowledge. Clinicians scored lowest, suggesting a trust gap that can undermine safer monitoring strategies.
08:22
Cessation findings show many men attempted quitting, yet relapse remained common afterward. Some returned to use after years abstinent, reflecting persistent perceived benefits and culture.
13:30
Harm reduction is framed like smoking cessation, using risk factors to guide targeted screening. Examples include coronary calcium testing and echocardiography to evaluate cardiovascular risk.
14:43
The discussion stresses that clinicians should recognize terms like tren, Deca, and SARMs. Better literacy is presented as a way to reduce stigma and improve patient trust.

Video Summary

An open-access research paper is discussed as a large survey of anabolic-androgenic steroid use in men. The project was designed because medical training often offers little education on steroid use patterns. Participants were adult men who reported anabolic steroid use within the previous five years. The survey examined starting age, typical dosing approaches, common compounds, and motivations for using drugs. Demographic findings described an average participant in the early thirties with wide international representation. Most respondents reported appearance improvement as a major goal, with strength gains also frequently cited. A substantial minority reported using steroids to boost self-esteem or address body image distress.

Body image topics are linked to body dysmorphia and muscle dysmorphia, which receive limited attention in men. The discussion suggests these concerns can drive risk-taking when physique improvement feels urgently needed. Healthcare engagement is described as inconsistent, with fewer than half disclosing steroid use to physicians. Among men who disclosed, many reported feeling judged or discriminated against during medical encounters. Those who withheld disclosure often cited fear of judgment and low confidence in clinician knowledge. A ranking exercise showed physicians scored lowest for steroid understanding compared with coaches and internet sources. The speakers argue that stigma and knowledge gaps reduce opportunities for safer monitoring and harm reduction.

Quitting attempts are described as common, yet relapse occurred for many men who tried stopping. Some respondents reportedly returned to use even after multiple years without anabolic drugs. The conversation frames this pattern as a combination of perceived benefits and social environment pressures. Harm reduction is emphasized through risk-based screening, similar to established approaches in smoking cessation. Cardiovascular monitoring is highlighted with examples like coronary calcium testing and echocardiography when indicated. Clinicians are encouraged to understand common terms like tren, Deca, Anavar, Anadrol, and SARMs. The closing message stresses that better education can improve trust and reduce preventable medical complications.

Drug Callouts

Drug
Description
Testosterone
Testosterone is an androgen hormone used medically for confirmed hypogonadism treatment. It is mentioned while contrasting testosterone replacement dosing with higher-dose steroid use.
Trenbolone
Trenbolone is a synthetic anabolic-androgenic steroid commonly nicknamed tren in gym culture. It appears as a buzzword clinicians should recognize when discussing compounds with steroid users.
Nandrolone decanoate (Deca)
Nandrolone decanoate is a long-acting anabolic steroid often called Deca by users. It is referenced as one of several terms that colleagues ask about during clinical conversations.
Oxandrolone (Anavar)
Oxandrolone is an oral anabolic steroid widely known by the brand name Anavar. It is cited as a common compound name that medical providers should understand in practice.
Oxymetholone (Anadrol)
Oxymetholone is a potent oral anabolic steroid typically known by the brand name Anadrol. It is listed among examples that illustrate how unfamiliar drug names can reduce patient trust.
SARMs
Selective androgen receptor modulators are experimental drugs abbreviated as SARMs by many users. They are mentioned as part of the vocabulary clinicians need to follow modern androgen trends.

Condition Callouts

Condition
Description
Body dysmorphia
Body dysmorphia is a mental health condition involving persistent distress about perceived appearance flaws. It is discussed as an underlying body image issue that can motivate steroid use for self-esteem.
Muscle dysmorphia
Muscle dysmorphia is a body image disorder where someone feels insufficiently muscular despite progress. It is mentioned as a factor that may drive desperate attempts to change physique using steroids.
Anorexia nervosa
Anorexia nervosa is an eating disorder marked by restrictive intake and intense fear of weight gain. It is used as a comparison point when discussing how male body image disorders receive less attention.
Heart attack
A heart attack occurs when coronary blood flow is blocked, injuring heart muscle tissue. It is cited as a catastrophic event that cardiovascular screening aims to help prevent.
Lung cancer
Lung cancer is a malignancy arising from lung tissue that can be screened in high-risk smokers. It is referenced while explaining harm-reduction style screening analogies for steroid risk assessment.

Key Takeaways

  • The survey included 2,385 men and is described as the largest of its kind.
  • Appearance and strength motives were common, with self-esteem concerns also reported frequently.
  • Fewer than half disclosed steroid use to physicians, and many reported feeling judged afterward.
  • Physicians were ranked lowest for steroid knowledge compared with coaches and online sources.
  • Harm reduction screening and better clinician education are presented as practical next steps.